标题
Functionalized gold nanoparticles improve afatinib delivery into cancer cells
作者
关键词
-
出版物
Expert Opinion on Drug Delivery
Volume 13, Issue 1, Pages 133-141
出版商
Informa Healthcare
发表日期
2015-09-16
DOI
10.1517/17425247.2015.1083973
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
- (2015) James Chih-Hsin Yang et al. LANCET ONCOLOGY
- Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo
- (2015) Siao-Syun Guan et al. Oncotarget
- Enhancing the Efficiency of Gold Nanoparticles Treatment of Cancer by Increasing Their Rate of Endocytosis and Cell Accumulation Using Rifampicin
- (2014) Moustafa R. K. Ali et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model
- (2014) Hao-Wen Kao et al. NANOTECHNOLOGY
- Enhanced cytotoxic activity of cetuximab in EGFR-positive lung cancer by conjugating with gold nanoparticles
- (2014) Yichun Qian et al. Scientific Reports
- Nanotechnology as a therapeutic tool to combat microbial resistance
- (2013) Robert Y. Pelgrift et al. ADVANCED DRUG DELIVERY REVIEWS
- Uptake of Engineered Gold Nanoparticles into Mammalian Cells
- (2013) Lev A. Dykman et al. CHEMICAL REVIEWS
- Gold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cells
- (2013) Sílvia Castro Coelho et al. Expert Opinion on Drug Delivery
- Enhancing Proteasome-Inhibitor Effect by Functionalized Gold Nanoparticles
- (2013) Sílvia Castro Coelho et al. Journal of Biomedical Nanotechnology
- Clinical perspective of afatinib in non-small cell lung cancer
- (2013) Xiaofeng Chen et al. LUNG CANCER
- Engineering of Targeted Nanoparticles for Cancer Therapy Using Internalizing Aptamers Isolated by Cell-Uptake Selection
- (2012) Zeyu Xiao et al. ACS Nano
- Gold nanoparticles as novel agents for cancer therapy
- (2012) S Jain et al. BRITISH JOURNAL OF RADIOLOGY
- Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma
- (2012) Yu-Chieh Tsai et al. EUROPEAN JOURNAL OF CANCER
- Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors
- (2012) A. H. Awada et al. INVESTIGATIONAL NEW DRUGS
- Quantitative Determination of Competitive Molecular Adsorption on Gold Nanoparticles Using Attenuated Total Reflectance–Fourier Transform Infrared Spectroscopy
- (2012) De-Hao Tsai et al. LANGMUIR
- Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin
- (2012) Joan Comenge et al. PLoS One
- Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
- (2011) N Ioannou et al. BRITISH JOURNAL OF CANCER
- Preparation of Peptide-Functionalized Gold Nanoparticles Using One Pot EDC/Sulfo-NHS Coupling
- (2011) Dorota Bartczak et al. LANGMUIR
- Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population
- (2011) Jong Ah Kim et al. Nature Nanotechnology
- BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- (2008) D Li et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started